60
Participants
Start Date
October 31, 2009
Primary Completion Date
March 31, 2011
Study Completion Date
April 30, 2011
Eviendep (CM&D Pharma Limited, UK)
175 mg milk thistle (fruit dry extract, 70% in silymarin)+ 20 mg flaxseed (dry extract, 40% in secoisolariciresinoldiglucoside)+750 mg non-starch, insoluble and indigestible fiber (6% in lignin). Provided in 5 g sachets, to be dissolved in half glass water, administered twice a day for 60 days on top of the common diet.
Maltodextrins
900 mg maltodextrin+excipient as per the active comparator eviendep, up to 5 g/sachet
Ospedale Policlinico Consorziale - Gastroenterology Unit, Bari
Lead Sponsor
CM&D Pharma Limited
INDUSTRY